Teva to pay $225 million fine and divest cholesterol drug to settle price-fixing charges
By Ramishah Maruf, CNN New York (CNN) — Teva Pharmaceuticals agreed to pay more than $200 million in fines and divest a key generic drug treating cholesterol to settle price-fixing charges from the US Department of Justice, the agency announced Monday. The settlement is the largest penalty paid “for a domestic antitrust cartel,” the DOJ
Continue Reading